Impact of genotype on clinical course in sickle cell disease and the utility of neutrophil-lymphocyte ratio: a ten-year single-institution experience

References

• Kato GJ, Piel FB, Reid CD, et al. Sickle cell disease. Nat Rev Dis Primers. 2018;4(1):18010. PubMed PMID: 29542687. doi: 10.1038/nrdp.2018.10
   PubMedGoogle Scholar
• Vekilov PG. Sickle-cell haemoglobin polymerization: is it the primary pathogenic event of sickle-cell anaemia? Br J Haematol. 2007;139(2):173–184. PubMed PMID: 17897293. doi: 10.1111/j.1365-2141.2007.06794.x
   PubMed Web of Science ®Google Scholar
• Rogers SC, Ross JGC, d’Avignon A, et al. Sickle hemoglobin disturbs normal coupling among erythrocyte O2 content, glycolysis, and antioxidant capacity. Blood. 2013;121(9):1651–1662. PubMed PMID: 23297128. doi: 10.1182/blood-2012-02-414037
   PubMed Web of Science ®Google Scholar
• Ochocinski D, Dalal M, Black LV, et al. Life-threatening infectious complications in sickle cell disease: a concise narrative review. Front Pediatr. 2020;8. PubMed PMID: 32154192.
   PubMed Web of Science ®Google Scholar
• Kavanagh PL, Fasipe TA, Wun T. Sickle cell disease: a review. JAMA. 2022;328(1):57–68. PubMed PMID: 35788790. doi: 10.1001/jama.2022.10233
   PubMed Web of Science ®Google Scholar
• Habara A, Steinberg MH. Minireview: genetic basis of heterogeneity and severity in sickle cell disease. Exp Biol Med (Maywood). 2016;241(7):689–696. PubMed PMID: 26936084. doi: 10.1177/1535370216636726
   PubMed Web of Science ®Google Scholar
• Quinn CT. Minireview: clinical severity in sickle cell disease: the challenges of definition and prognostication. Exp Biol Med (Maywood). 2016;241(7):679–688. PubMed PMID: 2701354. doi: 10.1177/1535370216640385
   PubMed Web of Science ®Google Scholar
• Conran N, Belcher JD, Connes P. Inflammation in sickle cell disease. Clin Hemorheol Microcirc. 2018;68(2–3):263–299. PubMed PMID: 29614637. doi: 10.3233/CH-189012
   PubMed Web of Science ®Google Scholar
• Okpala I. The intriguing contribution of white blood cells to sickle cell disease – a red cell disorder. Blood Rev. 2004;18(1):65–73. PubMed PMID: 14684149. doi: 10.1016/s0268-960x(03)00037-7
   PubMed Web of Science ®Google Scholar
• Zhang D, Xu C, Manwani D, et al. Neutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology. Blood. 2016;127(7):801–809. PubMed PMID: 26758915. doi: 10.1182/blood-2015-09-618538
   PubMed Web of Science ®Google Scholar
• Celikbilek A, Ismailogullari S, Zararsiz G. Neutrophil to lymphocyte ratio predicts poor prognosis in ischemic cerebrovascular disease. J Clin Lab Anal. 2014;28(1):27–31. PubMed PMID: 24375839. doi: 10.1002/jcla.21639
   PubMed Web of Science ®Google Scholar
• Park J-S, Seo K-W, Choi B-J, et al. Importance of prognostic value of neutrophil to lymphocyte ratio in patients with ST-elevation myocardial infarction. Medicine. 2018;97(48):e13471. PubMed PMID: 30508975. doi: 10.1097/MD.0000000000013471
   PubMed Web of Science ®Google Scholar
• Templeton AJ, McNamara MG, Šeruga B, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. JNCI. 2014;106(6):dju124. PubMed PMID: 24875653. doi: 10.1093/jnci/dju124
   PubMedGoogle Scholar
• Wun T. The role of inflammation and leukocytes in the pathogenesis of sickle cell disease; haemoglobinopathy. Hematology. 2001;5(5):403–412. PubMed PMID: 11399640. doi: 10.1080/10245332.2000.11746536
   PubMedGoogle Scholar
• Curtis SA, Danda N, Etzion Z, et al. Elevated steady State WBC and platelet counts are associated with frequent emergency room use in adults with sickle cell anemia. PLoS One. 2015;10(8):e0133116. PubMed PMID: 26248283. doi: 10.1371/journal.pone.0133116
   PubMed Web of Science ®Google Scholar
• Zahorec R. Neutrophil-to-lymphocyte ratio, past, present and future perspectives. Bratisl Med J. 2021;122(7):474–488. PubMed PMID: 34161115. doi: 10.4149/BLL_2021_078
   Google Scholar
• Wang Y, Zhao J, Yang L, et al. Value of the neutrophil-lymphocyte ratio in predicting COVID-19 severity: a meta-analysis. Dis Markers. 2021;2021:1–9. PubMed PMID: 34650648. doi: 10.1155/2021/2571912
   Web of Science ®Google Scholar
• Lowsby R, Gomes C, Jarman I, et al. Neutrophil to lymphocyte count ratio as an early indicator of blood stream infection in the emergency department. Al-Jubouri M, Ames D Anders J, et al., editors. 2015 32 531–534
   Google Scholar
• de Jager CPC, van Wijk PTL, Mathoera RB, et al. Lymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unit. Crit Care. 2010;14(5):R192. PubMed PMID: 21034463. doi: 10.1186/cc9309
   PubMed Web of Science ®Google Scholar
• Alagbe A, Olaniyi J. Pattern of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in sickle cell anemia patients at steady state and vaso-occlusive crisis. J Appl Hematol. 2019;10(2):45–50. doi: 10.4103/joah.joah_57_18
   Google Scholar
• Emokpae MA, Abdu A, Gwaram B. Neutrophil-to-lymphocyte, platelet-to-lymphocyte ratios and their association with atherogenic index of plasma in sickle cell nephropathy. J Appl Hematol. 2016;7(1):24–29. doi: 10.4103/1658-5127.181109
   Google Scholar
• Emokpae M, Aruomaren A, Osime E. Relationship between neutrophil-to-lymphocyte ratio and inflammatory markers in sickle cell anaemia patients with proteinuria. Med Sci. 2016;4(3):11. PubMed PMID: 29083375. doi: 10.3390/medsci4030011
   Google Scholar
• Cokic VP, Smith RD, Beleslin-Cokic BB, et al. Hydroxyurea induces fetal hemoglobin by the nitric oxide–dependent activation of soluble guanylyl cyclase. J Clin Invest. 2003;111(2):231–239. PubMed PMID: 12531879. doi: 10.1172/JCI16672
   PubMed Web of Science ®Google Scholar
• Zahran AM, Nafady A, Saad K, et al. Effect of hydroxyurea treatment on the inflammatory markers among children with sickle cell disease. Clin Appl Thromb Hemost. 2020;26:107602961989511. PubMed PMID: 31942811. doi: 10.1177/1076029619895111
   Web of Science ®Google Scholar
• Maharaj S, Chang SM, Xue R, et al. Performance of Neutrophil-to-Lymphocyte Ratio (NLR) in differentiating vaso-occlusive crisis from infection in patients presenting with sickle cell crisis. Blood. 2021;138(Supplement 1):4187. doi: 10.1182/blood-2021-154512
   Google Scholar
• Maharaj S, Chang S. Clinical utility of neutrophil to lymphocyte ratio in sickle cell disease with vaso-occlusive crisis. Hematol Oncol Stem Cell Ther. 2023;16:79–82. PubMed PMID: 36634279. doi: 10.56875/2589-0646.1046
   PubMedGoogle Scholar
• Platt OS, Thorington BD, Brambilla DJ, et al. Pain in sickle cell disease. N Engl J Med. 1991;325(1):11–16. PubMed PMID: 1710777. doi: 10.1056/NEJM199107043250103
   PubMed Web of Science ®Google Scholar
• Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood. 1998;91(1):288–294. PubMed PMID: 9414296.
   PubMed Web of Science ®Google Scholar
• Castro O, Brambilla DJ, Thorington B, et al. The acute chest syndrome in sickle cell disease: incidence and risk factors. Blood. 1994;84(2):643–649. PubMed PMID: 7517723. doi: 10.1182/blood.V84.2.643.643
   PubMed Web of Science ®Google Scholar
• Koshy M, Entsuah R, Koranda A, et al. Leg ulcers in patients with sickle cell disease [see comments]. Blood. 1989;74(4):1403–1408. PubMed PMID: 2475188. doi: 10.1182/blood.V74.4.1403.1403
   PubMed Web of Science ®Google Scholar
• Nolan VG, Wyszynski DF, Farrer LA, et al. Hemolysis-associated priapism in sickle cell disease. Blood. 2005;106(9):3264–3267. PubMed PMID: 15985542. doi: 10.1182/blood-2005-04-1594
   PubMed Web of Science ®Google Scholar
• Downes SM, Hambleton IR, Chuang EL, et al. Incidence and natural history of proliferative sickle cell retinopathy: observations from a cohort study. Ophthalmology. 2005;112(11):1869–1875. PubMed PMID: 16171867. doi: 10.1016/j.ophtha.2005.05.026
   PubMed Web of Science ®Google Scholar
• Milner PF, Kraus AP, Sebes JI, et al. Sickle cell disease as a cause of osteonecrosis of the femoral head. N Engl J Med. 1991;325(21):1476–1481. PubMed PMID: 1944426. doi: 10.1056/NEJM199111213252104
   PubMed Web of Science ®Google Scholar
• Proença-Ferreira R, Brugnerotto AF, Garrido VT, et al. Endothelial activation by platelets from sickle cell anemia patients. PLoS One. 2014;9(2):e89012–. PubMed PMID: 24551209. doi: 10.1371/journal.pone.0089012
   PubMed Web of Science ®Google Scholar